160 related articles for article (PubMed ID: 34408744)
1. Efficacy of Thymosin Alpha 1 in the Treatment of COVID-19: A Multicenter Cohort Study.
Liu J; Shen Y; Wen Z; Xu Q; Wu Z; Feng H; Li Z; Dong X; Huang S; Guo J; Zhang L; Chen Y; Li W; Zhu W; Du H; Liu Y; Wang T; Chen L; Teboul JL; Annane D; Chen D
Front Immunol; 2021; 12():673693. PubMed ID: 34408744
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of thymosin alpha 1 for severe sepsis (ETASS): a multicenter, single-blind, randomized and controlled trial.
Wu J; Zhou L; Liu J; Ma G; Kou Q; He Z; Chen J; Ou-Yang B; Chen M; Li Y; Wu X; Gu B; Chen L; Zou Z; Qiang X; Chen Y; Lin A; Zhang G; Guan X
Crit Care; 2013 Jan; 17(1):R8. PubMed ID: 23327199
[TBL] [Abstract][Full Text] [Related]
3. Thymosin Alpha-1 Has no Beneficial Effect on Restoring CD4+ and CD8+ T Lymphocyte Counts in COVID-19 Patients.
Wang Z; Chen J; Zhu C; Liu L; Qi T; Shen Y; Zhang Y; Xu L; Li T; Qian Z; Steinhart CR; Lu H
Front Immunol; 2021; 12():568789. PubMed ID: 34149679
[TBL] [Abstract][Full Text] [Related]
4. Thymosin α1 therapy in critically ill patients with COVID-19: A multicenter retrospective cohort study.
Wu M; Ji JJ; Zhong L; Shao ZY; Xie QF; Liu ZY; Wang CL; Su L; Feng YW; Liu ZF; Yao YM
Int Immunopharmacol; 2020 Nov; 88():106873. PubMed ID: 32795897
[TBL] [Abstract][Full Text] [Related]
5. Multisystem outcomes and predictors of mortality in critically ill patients with COVID-19: Demographics and disease acuity matter more than comorbidities or treatment modalities.
Alser O; Mokhtari A; Naar L; Langeveld K; Breen KA; El Moheb M; Kapoen C; Gaitanidis A; Christensen MA; Maurer LR; Mashbari H; Bankhead-Kendall B; Parks J; Fawley J; Saillant N; Mendoza A; Paranjape C; Fagenholz P; King D; Lee J; Farhat MR; Velmahos GC; Kaafarani HMA
J Trauma Acute Care Surg; 2021 May; 90(5):880-890. PubMed ID: 33891572
[TBL] [Abstract][Full Text] [Related]
6. Thymosin Alpha 1 Reduces the Mortality of Severe Coronavirus Disease 2019 by Restoration of Lymphocytopenia and Reversion of Exhausted T Cells.
Liu Y; Pan Y; Hu Z; Wu M; Wang C; Feng Z; Mao C; Tan Y; Liu Y; Chen L; Li M; Wang G; Yuan Z; Diao B; Wu Y; Chen Y
Clin Infect Dis; 2020 Nov; 71(16):2150-2157. PubMed ID: 32442287
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology and Outcomes of Acute Kidney Injury in COVID-19 Patients with Acute Respiratory Distress Syndrome: A Multicenter Retrospective Study.
Wang F; Ran L; Qian C; Hua J; Luo Z; Ding M; Zhang X; Guo W; Gao S; Gao W; Li C; Liu Z; Li Q; Ronco C
Blood Purif; 2021; 50(4-5):499-505. PubMed ID: 33291098
[TBL] [Abstract][Full Text] [Related]
8. Continuous renal replacement therapy with the addition of CytoSorb cartridge in critically ill patients with COVID-19 plus acute kidney injury: A case-series.
Alharthy A; Faqihi F; Memish ZA; Balhamar A; Nasim N; Shahzad A; Tamim H; Alqahtani SA; Brindley PG; Karakitsos D
Artif Organs; 2021 May; 45(5):E101-E112. PubMed ID: 33190288
[TBL] [Abstract][Full Text] [Related]
9. Gender-associated difference following COVID-19 virus infection: Implications for thymosin alpha-1 therapy.
Li X; Liu L; Yang Y; Yang X; Wang C; Li Y; Ge Y; Shi Y; Lv P; Zhou H; Luo P; Huang S
Int Immunopharmacol; 2021 Jan; 90():107022. PubMed ID: 33160854
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of corticosteroids in non-intensive care unit patients with COVID-19 pneumonia from the New York Metropolitan region.
Majmundar M; Kansara T; Lenik JM; Park H; Ghosh K; Doshi R; Shah P; Kumar A; Amin H; Chaudhari S; Habtes I
PLoS One; 2020; 15(9):e0238827. PubMed ID: 32903258
[TBL] [Abstract][Full Text] [Related]
11. Coronavirus Disease 2019 ICU Patients Have Higher-Than-Expected Acute Physiology and Chronic Health Evaluation-Adjusted Mortality and Length of Stay Than Viral Pneumonia ICU Patients.
Higgins TL; Stark MM; Henson KN; Freeseman-Freeman L
Crit Care Med; 2021 Jul; 49(7):e701-e706. PubMed ID: 33861555
[TBL] [Abstract][Full Text] [Related]
12. The Therapeutic Effects of Thymosin α1 Combined with Human Immunoglobulin (Ig) and Bundles on Severe Sepsis: a Retrospective Study.
Li Y; Li CS
Clin Lab; 2015; 61(8):907-16. PubMed ID: 26427133
[TBL] [Abstract][Full Text] [Related]
13. Increased extravascular lung water index (EVLWI) reflects rapid non-cardiogenic oedema and mortality in COVID-19 associated ARDS.
Rasch S; Schmidle P; Sancak S; Herner A; Huberle C; Schulz D; Mayr U; Schneider J; Spinner CD; Geisler F; Schmid RM; Lahmer T; Huber W
Sci Rep; 2021 Jun; 11(1):11524. PubMed ID: 34075155
[TBL] [Abstract][Full Text] [Related]
14. Patient characteristics, clinical course and factors associated to ICU mortality in critically ill patients infected with SARS-CoV-2 in Spain: A prospective, cohort, multicentre study.
Ferrando C; Mellado-Artigas R; Gea A; Arruti E; Aldecoa C; Bordell A; Adalia R; Zattera L; Ramasco F; Monedero P; Maseda E; Martínez A; Tamayo G; Mercadal J; Muñoz G; Jacas A; Ángeles G; Castro P; Hernández-Tejero M; Fernandez J; Gómez-Rojo M; Candela Á; Ripollés J; Nieto A; Bassas E; Deiros C; Margarit A; Redondo FJ; Martín A; García N; Casas P; Morcillo C; Hernández-Sanz ML;
Rev Esp Anestesiol Reanim (Engl Ed); 2020 Oct; 67(8):425-437. PubMed ID: 32800622
[TBL] [Abstract][Full Text] [Related]
15. Acute Kidney Injury in Patients with the Coronavirus Disease 2019: A Multicenter Study.
Cui X; Yu X; Wu X; Huang L; Tian Y; Huang X; Zhang Z; Cheng Z; Guo Q; Zhang Y; Cai Y; Zhan Q
Kidney Blood Press Res; 2020; 45(4):612-622. PubMed ID: 32712607
[TBL] [Abstract][Full Text] [Related]
16. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
[TBL] [Abstract][Full Text] [Related]
17. Acute Kidney Injury and Renal Replacement Therapy in Critically Ill COVID-19 Patients: Risk Factors and Outcomes: A Single-Center Experience in Brazil.
Doher MP; Torres de Carvalho FR; Scherer PF; Matsui TN; Ammirati AL; Caldin da Silva B; Barbeiro BG; Carneiro FD; Corrêa TD; Ferraz LJR; Dos Santos BFC; Pereira VG; Batista MC; Monte JCM; Santos OFP; Bellomo R; Serpa Neto A; Durão MS
Blood Purif; 2021; 50(4-5):520-530. PubMed ID: 33341806
[TBL] [Abstract][Full Text] [Related]
18. Metabolic Syndrome and Acute Respiratory Distress Syndrome in Hospitalized Patients With COVID-19.
Denson JL; Gillet AS; Zu Y; Brown M; Pham T; Yoshida Y; Mauvais-Jarvis F; Douglas IS; Moore M; Tea K; Wetherbie A; Stevens R; Lefante J; Shaffer JG; Armaignac DL; Belden KA; Kaufman M; Heavner SF; Danesh VC; Cheruku SR; St Hill CA; Boman K; Deo N; Bansal V; Kumar VK; Walkey AJ; Kashyap R;
JAMA Netw Open; 2021 Dec; 4(12):e2140568. PubMed ID: 34935924
[TBL] [Abstract][Full Text] [Related]
19. High dose dexamethasone treatment for Acute Respiratory Distress Syndrome secondary to COVID-19: a structured summary of a study protocol for a randomised controlled trial.
Maskin LP; Olarte GL; Palizas F; Velo AE; Lurbet MF; Bonelli I; Baredes ND; Rodríguez PO
Trials; 2020 Aug; 21(1):743. PubMed ID: 32843098
[TBL] [Abstract][Full Text] [Related]
20. A Comparison of Clinical Characteristics and Outcomes in Elderly and Younger Patients with COVID-19.
Song J; Hu W; Yu Y; Shen X; Wang Y; Yan J; Yang X; Gong S; Wang M
Med Sci Monit; 2020 Jul; 26():e925047. PubMed ID: 32720649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
